Literature DB >> 24976917

Impact of conditioning hyperglycemic on myocardial infarction rats: Cardiac cell survival factors.

Christiane Malfitano1, Alcione Lescano de Souza Junior1, Maria Cláudia Irigoyen1.   

Abstract

While clinical data have suggested that the diabetic heart is more susceptible to ischemic heart disease (IHD), animal data have so far pointed to a lower probability of IHD. Thus, the aim of this present review is to look at these conflicting results and discuss the protective mechanisms that conditioned hyperglycemia may confer to the heart against ischemic injury. Several mechanisms have been proposed to explain the cardioprotective action of high glucose exposure, namely, up-regulation of anti-apoptotic factor Bcl-2, inactivation of pro-apoptotic factor bad, and activation of pro-survival factors such as protein kinase B (Akt), vascular endothelial growth factor (VEGF), hypoxia inducible factor-1α and protein kinase C-ε. Indeed, cytosolic increase in Ca(2+) concentration, the mitochondrial permeability transition pore, plays a key role in the genesis of ischemic injury. Previous studies have shown that the diabetic heart decreased Na(+)/Ca(2+) and Na(+)/H(+) exchanger activity and as such it accumulates less Ca(2+) in cardiomyocyte, thus preventing cardiac injury and the associated heart dysfunctions. In addition, the expression of VEGF in diabetic animals leads to increased capillary density before myocardial infarction. Despite poor prognostic in the long-term, all these results suggest that diabetes mellitus and consequently hyperglycemia may indeed play a cardioprotective role against myocardial infarction in the short term.

Entities:  

Keywords:  Cardioprotection; Conditioned hyperglycemia; Diabetes mellitus; Myocardial infarction; Survival factors

Year:  2014        PMID: 24976917      PMCID: PMC4072835          DOI: 10.4330/wjc.v6.i6.449

Source DB:  PubMed          Journal:  World J Cardiol


  48 in total

Review 1.  Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis.

Authors:  G L Semenza
Journal:  J Lab Clin Med       Date:  1998-03

2.  Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria.

Authors:  Christopher P Baines; Chang-Xu Song; Yu-Ting Zheng; Guang-Wu Wang; Jun Zhang; Ou-Li Wang; Yiru Guo; Roberto Bolli; Ernest M Cardwell; Peipei Ping
Journal:  Circ Res       Date:  2003-03-27       Impact factor: 17.367

3.  Hyperglycaemia protects the heart after myocardial infarction: aspects of programmed cell survival and cell death.

Authors:  Christiane Malfitano; Tatiana C Alba Loureiro; Bruno Rodrigues; Raquel Sirvente; Vera Maria Cury Salemi; Nara B Rabechi; Silvia Lacchini; Rui Curi; Maria Claudia C Irigoyen
Journal:  Eur J Heart Fail       Date:  2010-04-20       Impact factor: 15.534

4.  The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery.

Authors:  Hiroaki Sato; George Carvalho; Tamaki Sato; Ralph Lattermann; Takashi Matsukawa; Thomas Schricker
Journal:  J Clin Endocrinol Metab       Date:  2010-07-14       Impact factor: 5.958

5.  Contradictory effects of short- and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway.

Authors:  Guang Xu; En Takashi; Mitsuhiro Kudo; Toshiyuki Ishiwata; Zenya Naito
Journal:  Exp Mol Pathol       Date:  2004-02       Impact factor: 3.362

6.  Interleukin-8 as a macrophage-derived mediator of angiogenesis.

Authors:  A E Koch; P J Polverini; S L Kunkel; L A Harlow; L A DiPietro; V M Elner; S G Elner; R M Strieter
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

7.  Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production.

Authors:  G Baffy; T Miyashita; J R Williamson; J C Reed
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

8.  Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions.

Authors:  M Gwechenberger; L H Mendoza; K A Youker; N G Frangogiannis; C W Smith; L H Michael; M L Entman
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

Review 9.  Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.

Authors:  Elizabeth Murphy; Charles Steenbergen
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

10.  National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; John K Lin; Gitanjali M Singh; Christopher J Paciorek; Melanie J Cowan; Farshad Farzadfar; Gretchen A Stevens; Stephen S Lim; Leanne M Riley; Majid Ezzati
Journal:  Lancet       Date:  2011-02-03       Impact factor: 79.321

View more
  3 in total

1.  Mild Type 2 Diabetes Mellitus Reduces the Susceptibility of the Heart to Ischemia/Reperfusion Injury: Identification of Underlying Gene Expression Changes.

Authors:  Sevil Korkmaz-Icöz; Alice Lehner; Shiliang Li; Adrian Vater; Tamás Radovits; Péter Hegedűs; Mihály Ruppert; Paige Brlecic; Markus Zorn; Matthias Karck; Gábor Szabó
Journal:  J Diabetes Res       Date:  2015-07-01       Impact factor: 4.011

2.  Diabetic hyperglycemia attenuates sympathetic dysfunction and oxidative stress after myocardial infarction in rats.

Authors:  Christiane Malfitano; Catarina Andrade Barboza; Cristiano Mostarda; Renata Kelly da Palma; Camila Paixão dos Santos; Bruno Rodrigues; Sarah Cristina Ferreira Freitas; Adriane Belló-Klein; Susana Llesuy; Maria-Cláudia Irigoyen; Kátia De Angelis
Journal:  Cardiovasc Diabetol       Date:  2014-10-10       Impact factor: 9.951

3.  Glucose and fatty acid metabolism in infarcted heart from streptozotocin-induced diabetic rats after 2 weeks of tissue remodeling.

Authors:  Christiane Malfitano; Alcione Lescano de Souza Junior; Mariana Carbonaro; Andressa Bolsoni-Lopes; Diego Figueroa; Leandro Ezequiel de Souza; Kleiton Augusto Santos Silva; Fernanda Consolim-Colombo; Rui Curi; Maria Claudia Irigoyen
Journal:  Cardiovasc Diabetol       Date:  2015-11-09       Impact factor: 9.951

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.